For patients not benefiting from neonatal screening with equivocal ST, investigating CFTR function (NPD or intestinal current measurement) is advised, leading to classification as CFTR-Related Metabolic Syndrome (CRMS) if the genetic test remains inconclusive [29]. Here, CFTR is linked to metabolic syndrome.